Top Tweets for #oxMIF
The team of @OncoOne is developing a pipeline of therapeutic antibodies capable of targeting #oxMIF, the disease-related isoform of MIF. Video produced by @biolution_net. Both are #partofviennabiocenter https://t.co/YXPUcnPRJ7
Join @OncoOne's CTO Alexander Schinagl at #PEGS23 Boston for his talk "Pretargeted Radioimmunotherapy with an Anti-oxMIF/HSG Bispecific Antibody Demonstrates Efficacy in Murine Models of Cancer" today from 5:30 to 6:00 PM (ET) in Ballroom A. #oxMIF #PreTargit #radioimmunotherapy
Meet @OncoOne at #IMMUNOLOGY2023 in Washington DC! Join us to listen to Maroua's talk on our novel antibody ON104 targeting oxidized macrophage migration inhibitory factor (#oxMIF) & meet us at our poster #860.
See you on May 12th & 13th! #immunology #inflammation #AAI2023
#BIOEuropeSpring starts today so be sure to join our management team to learn more about OncoOne’s recent corporate developments & to see where we are headed with our pipeline targeting #oxMIF in #cancer & #inflammation. Schedule a 1:1 meeting with us for further details.
Join our Senior Scientist, Barbara Maurer today for her talk entitled “#ON203 - A new antibody targeting #oxMIF exerts antitumorigenic activity and modulates the tumor microenvironment” at the #NEXTGenIO Conference in London at 3:15 pm GMT.
Today our CBO, @RbrentMeadows, & Director Preclinical & Project Lead Inflammation, Christine Landlinger-Schubert are in Philadelphia for the #ACR22. Don’t miss her poster presentation on the capabilities of #oxMIF as a target in a novel treatment approach for rheumatoid arthritis
Congratulations to our CSO, Michael Thiele on the publication of his review article, “OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases” published in @jitcancer. Click below to learn more about #oxMIF’s therapeutic potential.
New #JITC review: OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases https://t.co/N23vtzwi4O
#Savethedate: Next stop for our CEO, Randolf Kerschbaumer is the #Macrophage-directed Therapies Summit in Boston from Oct. 4-6. Dr. Kerschbaumer will be discussing the potential of our optimized antibody, #ON104, targeting #oxMIF in patients with inflammatory conditions.
#BIO2022 is back & OncoOne’s CEO, Randolf Kerschbaumer & CBO, @RBrentMeadows will give a corporate presentation on June 15 at 4:45 PM PDT on our innovative #oxMIF-targeting pipeline in #oncology & #immunology. See you in San Diego!
Today is the start of the 22nd #BioEquity Europe, hosted by @BioCentury. Our CBO, @RBrentMeadows, will be available in Milan to talk about #ON203 and #ON104, our lead clinical candidates targeting #oxMIF for solid tumors and immunology set to enter phase I testing next year.
#SavetheDate: OncoOne will be a member of the Presenting Company Class at the 22nd #BioEquity Europe in Milan. Our CBO, @RBrentMeadows, will be presenting a corporate overview during the Hot Topics Track #3 on Wednesday, May 18th at 12:18pm CET. We hope to see you there!
Learn more about our commitment to developing innovative drug modalities that leverage the full potential of #oxMIF as a target from our CSO, Michael Thiele, at next week’s #PharmaKON Future Forum in Vienna, May 10-11. Find out where you can see us next at https://t.co/WlUPZUmm8a
Join us in supporting National Cancer Research Month (#NCRM22) in the U.S. At #OncoOne, we understand the impact research such as our own #oxMIF targeted approach can have on future generations living with #cancer. Visit https://t.co/msjJrbhfmM to discover how #researchsaveslives
#BIOEuropeSpring starts today so be sure to join our management team to learn more about OncoOne’s recent corporate developments & to see where we are headed with our pipeline targeting #oxMIF in #cancer & #inflammation. Schedule a 1:1 meeting with us for further details.
Our newly updated website is now live! Please visit https://t.co/Pk0vqyG8cZ to view our new layout and learn more about our innovative approach to targeting #oxMIF and the introduction of our #PreTargit™ modular platform.
#SavetheDate: OncoOne management will have a virtual presentation available for participants at #BIOEuropeSpring. Schedule meetings with us from March 28 – 31 to learn more about our unique #oxMIF-targeting approach to various #cancer & #inflammation.
Each member of the OncoOne team is an important piece of our story and works diligently to advance our #oxMIF based therapeutics towards clinical evaluation next year. Happy #EmployeeAppreciationDay to an amazing team!
Did you know that the OncoOne founders discovered the untapped potential of #oxMIF as an attractive target for a range of solid tumors and inflammatory conditions? Head over to our website at, https://t.co/Pk0vqyG8cZ to learn more about our innovative technology.
Last Seen Hashtags on Sotwe
omegle() filter:videos
Seen from United States
DitchLIndseyGraham2020
Seen from United States
omegle
Seen from Pakistan
paymyrent
Seen from India
gacha whore
Seen from United States
여장
Seen from Indonesia
여장남자
omegle(**********************(***)*********************) filter:videos
Seen from Ukraine
solo #pussy
Seen from South Africa
omegle
Seen from United Kingdom
Most Popular Users
Elon Musk 
@elonmusk
241.6M followers
Barack Obama
@barackobama
119M followers
Cristiano Ronaldo
@cristiano
114.1M followers
Donald J. Trump
@realdonaldtrump
111.8M followers
Narendra Modi
@narendramodi
107.2M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.4M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
89.8M followers
Taylor Swift
@taylorswift13
83.8M followers
Lady Gaga
@ladygaga
75.3M followers
Virat Kohli
@imvkohli
73M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.8M followers
Neymar Jr
@neymarjr
66.1M followers
Bill Gates
@billgates
65M followers
Selena Gomez
@selenagomez
62.9M followers
The Ellen Show
@theellenshow
62.3M followers
CNN
@cnn
61.8M followers
X
@x
60.7M followers